A fibroadenoma that is left alone rarely prevents breastfeeding. Research comparing women who had untreated fibroadenomas with those who had them surgically removed or ablated found that the untreated group had a complete lactation failure rate of only about 4%, while both surgical and radiofrequency ablation groups saw failure rates around 15 to 16 percent. In other words, the lump itself is far less likely to interfere with nursing than the procedures used to remove it. That said, the full picture involves hormonal changes during pregnancy, the location and size of the mass, and what happens if surgery becomes necessary before or during the breastfeeding period.
What Happens to a Fibroadenoma During Pregnancy and Lactation
Fibroadenomas are benign breast lumps made up of glandular tissue and connective tissue. They are common in women of reproductive age, and many women discover one for the first time during pregnancy, when the breast tissue is undergoing dramatic remodeling. The hormonal surge of pregnancy, particularly the rise in estrogen, progesterone, and prolactin, drives ductal growth and the formation of milk-producing structures throughout the breast. Fibroadenomas respond to these same hormones and can enlarge, sometimes significantly, during pregnancy and lactation.1PubMed Central. Giant Fibroadenoma Growing Rapidly During Pregnancy Some fibroadenomas also undergo internal changes such as infarction, cyst formation, prominent ductal widening, and secretory hyperplasia, all of which mirror the changes happening in the surrounding normal breast tissue.2PubMed. Radiologic evaluation of breast disorders related to pregnancy and lactation
This growth can be alarming. A lump that was barely noticeable before conception may become easily palpable or visibly distort the breast shape during the second or third trimester. In one longitudinal study of pregnant women in Nigeria, fibroadenomas accounted for about 10% of lesions identified by breast ultrasound during pregnancy and the postpartum period.3PubMed Central. A longitudinal study of the prevalence and characteristics of breast disorders detected by clinical breast examination during pregnancy and six months postpartum in Ibadan, Southwestern Nigeria Despite the size change, fibroadenomas remain benign. They do not become cancerous during pregnancy, and the enlargement is typically driven by the same hormonal engine that is preparing the breast for milk production rather than by any worrisome cellular transformation.
Why the Lump Itself Usually Does Not Block Milk Flow
Breast milk travels through a branching system of ducts that converge at the nipple. A fibroadenoma sits within the breast tissue but does not grow into or replace the ductal system. It pushes ducts aside rather than destroying them, which is why an untreated fibroadenoma rarely disrupts the mechanics of lactation. A retrospective study comparing breastfeeding outcomes found that women with fibroadenomas who simply continued to be observed had a complete lactation failure rate of about 3.6%, a figure low enough to suggest that the lump alone is not the bottleneck for most women.4PubMed. Breastfeeding Outcomes After Radiofrequency Ablation and Surgical Excision of Fibroadenomas Compared to Natural History: A Retrospective Cohort Study
There are exceptions. A very large fibroadenoma, sometimes called a giant fibroadenoma when it exceeds five centimeters, can compress a significant portion of the ductal network on one side, reducing milk output from that breast. And if the fibroadenoma sits directly behind the nipple-areolar complex, the pressure it exerts on the collecting ducts may make latch or milk transfer more difficult for the infant. Still, even with a large mass, many women are able to nurse from the affected breast with adjusted positioning, and they can compensate with increased feeding from the unaffected side.
When Surgical Removal Changes the Equation
The real risk to breastfeeding comes less from the fibroadenoma itself and more from what is done about it. Excisional biopsy or lumpectomy requires cutting through breast tissue, and that means cutting through ducts, small blood vessels, and nerves. If the surgery happens close to the nipple-areolar area, it can sever the main collecting ducts, impairing milk drainage. Peripheral incisions are less disruptive but can still damage the tissue that feeds into those ducts.
In the retrospective study mentioned earlier, the surgical excision group had a complete lactation failure rate of 16%, compared to 3.6% among women whose fibroadenomas were only observed. Radiofrequency ablation, a less invasive technique that destroys the fibroadenoma with heat delivered through a needle, showed a similar failure rate of about 14.6%. The study authors concluded that both procedures effectively treat the fibroadenoma but increase the risk of complete lactation failure compared to leaving the lump alone.4PubMed. Breastfeeding Outcomes After Radiofrequency Ablation and Surgical Excision of Fibroadenomas Compared to Natural History: A Retrospective Cohort Study Residual tissue left behind after ablation also correlated with lactation impairment, suggesting that incomplete treatment may cause scarring or distortion that hampers milk flow even when the visible mass is gone.
A separate survey of women who had undergone surgery for benign breast disease found that about 91% breastfed at least once after surgery, which is slightly below the national average but not dramatically so. However, exclusive breastfeeding at six months was actually higher than the national average in that group, at roughly 41% versus 29%. The catch appeared later: breastfeeding at twelve months was only about 30%, well below the national average of 66.5%. The most commonly reported reason for stopping early was insufficient milk supply, and about 29% of women who did breastfeed said they voluntarily reduced the frequency and duration of nursing on the operated breast because of the surgery.5PubMed Central. A survey of breastfeeding among women with previous surgery for benign breast disease: a descriptive exploratory study
That last finding is worth pausing on. Nearly a third of women chose to nurse less on the surgical side not because they physically could not, but because of worry or discomfort about the operated breast. Anxiety about whether the breast is working properly, whether milk from that side is safe, or whether nursing will somehow harm the surgical site leads some women to favor the unoperated breast. Over time, reduced stimulation on one side can lower milk production there, creating a self-fulfilling cycle where the operated breast really does produce less milk, not because of the surgery per se but because it is nursed less often.
Can You Breastfeed While a Fibroadenoma Is Still Present?
Yes, and many women do. If the fibroadenoma has been diagnosed by imaging and confirmed as benign, there is no medical reason it should prevent you from nursing. The lump does not contaminate the milk or make it unsafe. Milk produced by the tissue around a fibroadenoma is identical to milk from any other part of the breast, because the fibroadenoma itself is not secretory tissue; it sits alongside the milk-producing lobules rather than replacing them.
Practical challenges tend to center on comfort and latch. A large or superficial fibroadenoma may create a firm area that makes positioning the baby difficult. Some women notice that the baby has a harder time latching on the affected side, especially if the lump distorts the shape of the areola. Lactation consultants typically recommend experimenting with different feeding positions, such as the football hold or side-lying, to work around the lump. If one breast consistently produces less, feeding more frequently from that side can help maintain supply, though some women opt to rely primarily on the other breast and supplement if needed.
Surgery During Lactation
Occasionally a fibroadenoma grows so large during pregnancy or the postpartum period that it causes significant discomfort, skin stretching, or diagnostic uncertainty. When the mass needs to come out while the woman is still breastfeeding, the question is whether lactation can continue afterward. Case reports describe successful excision of giant fibroadenomas during the postpartum period with continued breastfeeding. One published case involved a woman who had a large fibroepithelial lesion removed at four months postpartum and was able to maintain lactation through the recovery.6BMJ Case Reports. Surgical management of a giant fibroadenoma during lactation
The key surgical consideration is preserving as much ductal architecture as possible. Surgeons who are experienced with breast-conserving techniques in lactating women tend to use periareolar or inframammary incisions that spare the main ducts running toward the nipple. Milk fistula, a complication where milk leaks through the surgical wound, is a theoretical concern but appears to be uncommon in practice. A study of women who continued breastfeeding after various breast interventions, including mass excisions, found that the incidence of fistula was low enough that risk factors could not even be quantitatively evaluated.7PubMed. Low incidence of milk fistula with continued breastfeeding following radiologic and surgical interventions on the lactating breast In other words, continuing to nurse after surgery is generally feasible and does not create the wound-healing problems that many women fear.
Fibroadenoma Versus Lactating Adenoma
A lump that appears for the first time during pregnancy or lactation sometimes turns out not to be a fibroadenoma at all, but a lactating adenoma, a different benign mass that arises specifically in response to the hormonal environment of pregnancy. The distinction matters because the two behave differently after the baby is born. A lactating adenoma tends to shrink or disappear entirely once breastfeeding ends, while a fibroadenoma may or may not regress.
Under a microscope, the two look quite different. A fibroadenoma contains both glandular and stromal (connective tissue) components, while a lactating adenoma is almost entirely epithelial, made up of cells showing active milk-secretion changes with very little stroma.8PubMed Central. Lactating Adenoma in Pregnancy: Report of Three Cases This difference is what pathologists use to tell them apart, and the presence of a significant stromal component is generally enough to distinguish a fibroadenoma from a lactating adenoma.9PubMed. Breast tumour of pregnancy (‘lactating’ adenoma) Neither type is dangerous, and both can coexist with normal breastfeeding, but your doctor may want a core needle biopsy to settle the diagnosis, especially if the lump is growing quickly.
Imaging during lactation adds its own wrinkle. The lactating breast is denser and more vascular than usual, which makes ultrasound interpretation trickier. The differential diagnosis for a solid breast mass in a lactating woman includes not just fibroadenoma and lactating adenoma, but also focal mastitis, a phyllodes tumor, and, rarely, breast cancer.10PubMed Central. Imaging of Lactating Adenoma: Differential Diagnosis of Solid Mass Lesion in a Lactating Woman That list is one reason clinicians take new or growing lumps seriously even though most turn out to be benign.
What Happens After Weaning
Once breastfeeding ends and hormone levels return to their pre-pregnancy baseline, fibroadenomas that enlarged during pregnancy often shrink back down. Some resolve entirely over months to years. A review of fibroadenoma management noted that regression or complete resolution is frequent, which supports a conservative watch-and-wait approach rather than rushing to remove every lump.11PubMed Central. Management of breast fibroadenomas This natural tendency to regress is one reason many specialists recommend deferring surgery until after breastfeeding is complete, unless the mass is causing significant symptoms or diagnostic concern.
For women who are anxious about the lump, this waiting period can be psychologically difficult. Regular ultrasound monitoring every six to twelve months is the typical compromise, allowing the clinician to confirm that the mass is behaving as expected without subjecting the patient to a procedure that could compromise her breastfeeding goals. If the fibroadenoma does not shrink within a year or two of weaning, excision at that point carries far less risk to future lactation, because the ductal system is no longer actively producing milk and has time to heal before any subsequent pregnancy.
Do Pregnancy and Breastfeeding Affect Your Risk of Developing Fibroadenomas?
There is a curious flip side to the question. Not only does a fibroadenoma mostly not affect breastfeeding, but pregnancy and breastfeeding may actually influence fibroadenoma risk going forward. A case-control study in Australia found that the risk of developing a fibroadenoma decreased with an increasing number of full-term pregnancies.12American Journal of Epidemiology. Risk Factors for Fibroadenoma: A Case-Control Study in Australia The protective effect of parity (having given birth) is consistent with what is seen for several other benign and malignant breast conditions, and is thought to relate to the long-term remodeling of breast tissue that occurs with each completed pregnancy.
Whether breastfeeding itself provides additional protection beyond pregnancy is less clear. One study found that among women with fibroadenoma, the duration of breastfeeding correlated with the number of benign lesions, an association that held even after adjusting for other variables.13PubMed. Breast-feeding and benign breast disease That finding is a bit counterintuitive, since it implies longer breastfeeding was linked to more lesions, not fewer, though the relationship could reflect confounding factors like the hormonal environment of women who are able to breastfeed for extended periods. A separate study looking at dietary and reproductive risk factors in Chinese women found that after adjusting for parity, lactation duration was not independently associated with fibroadenoma risk.14The Journal of Nutrition. Fruit and Vegetable Intakes Are Associated with Lower Risk of Breast Fibroadenomas in Chinese Women The evidence here is genuinely mixed, and researchers have gone back and forth on whether breastfeeding confers a measurable independent benefit against benign breast lumps or whether the protection is really coming from pregnancy itself.
Practical Decisions for Women With a Known Fibroadenoma
If you have been told you have a fibroadenoma and you are pregnant or planning to breastfeed, the most useful framing is that the lump is overwhelmingly unlikely to stop you from nursing. The vast majority of women with untreated fibroadenomas breastfeed without significant difficulty. The practical steps that make the biggest difference are straightforward:
- Get a clear diagnosis: A core needle biopsy or imaging confirmation before or during pregnancy removes the anxiety of wondering whether the lump is something more serious. That peace of mind often matters as much as anything for breastfeeding success.
- Defer surgery if possible: Unless the fibroadenoma is causing pain, growing rapidly, or raising diagnostic red flags, waiting until after breastfeeding is complete preserves ductal integrity and avoids the elevated risk of lactation failure associated with both surgical excision and ablation.
- Monitor size changes: Expect the lump to grow during pregnancy and lactation. A size increase alone does not mean something is wrong, but your provider should track it with periodic ultrasound to make sure the growth pattern is consistent with a benign process.
- Feed from both sides: If you are nervous about the breast with the fibroadenoma, it is tempting to avoid nursing from that side. Resist the urge. Regular stimulation maintains milk supply, and underusing one breast is the most common pathway to lopsided production and early weaning.
Women who have already had a fibroadenoma removed before pregnancy face a different set of concerns. The key variable is where the surgical scar is. A scar near the nipple or in the upper central quadrant, where the main ducts converge, is more likely to affect milk transport than one in the periphery. If you know you had breast surgery and are planning to breastfeed, letting your obstetrician and a lactation consultant know ahead of time helps set realistic expectations and ensures you get support early rather than troubleshooting a supply problem weeks into nursing.
When to Worry About a Breast Lump During Lactation
Most breast lumps discovered during pregnancy or breastfeeding turn out to be benign. But “most” is not “all,” and the hormonal and structural changes of lactation can mask a more concerning process. Any new lump that is hard, fixed to surrounding tissue, associated with skin changes like dimpling or redness, or accompanied by bloody nipple discharge should be evaluated promptly. Breast cancer during pregnancy and lactation is uncommon but not unheard of, and delayed diagnosis is a well-documented problem because both patients and clinicians tend to attribute lumps to the normal changes of lactation.
Ultrasound is the first-line imaging tool for evaluating a breast mass during pregnancy and lactation, since it avoids radiation and performs well in dense breast tissue. If a lump scores high on the standard imaging classification scale, a tissue sample through core needle biopsy can be done safely during breastfeeding. Nursing or pumping right before the biopsy to empty the breast reduces engorgement and lowers the small risk of milk fistula at the needle site. The goal is never to let concern about breastfeeding delay the workup of a suspicious finding.